3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
54
Colorectal Neoplasms
10
Uterine Cervical Neoplasms
6
Prostatic Neoplasms
6
Breast Carcinoma In Situ
6
Ovarian Neoplasms
5
Neoplasms
5
Lung Neoplasms
5
Colonic Neoplasms
5
Triple Negative Breast Neoplasms
4
Endometrial Neoplasms
4
Depression
4
Vulvar Neoplasms
3
Urinary Bladder Neoplasms
3
Rectal Neoplasms
3
Obesity
3
Motor Activity
3
Lymphoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Anxiety Disorders
3
Anatomic Stage I Breast Cancer AJCC v8
3
Vaginal Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Lymphedema
2
Leukemia
2
Kidney Neoplasms
2
Genital Neoplasms, Female
2
Fatigue
2
Weight Loss
1
Interventions
pembrolizumab
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Fulvestrant
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
seribantumab
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
durvalumab
1
defactinib
1
dabrafenib
1
copanlisib
1
cemiplimab
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Methods
×
Breast
×
Clear all
NCT05939440
2025-06-05
P-COC
University of Alabama at Birmingham
Phase NA
Completed
60 enrolled